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Non-polypoidal, synchronous mantle- cell










Herein is reported the case of a mantle cell lymphoma (MCL) with synchronous double intestinal location. A 74 -
year old male presented with mild abdominal pain. CT scan imaging indicated invasion of lateral intestinal cavity
by large mass formation. Exploratory laparotomy was performed and two solid extra-mural masses were isolated
and excised. Histology revealed non- polypoid double synchronous lymphoma of mantle cell origin, an unusual
presentation of the disease.
Background
Mantle cell lymphoma (ICD-O code 9673/3) is a sub-
type in the wide category of B- cell lymphomas [1,2]. It
i sas p e c i f i ct y p eo fN o n -H o d g k i n ’s lymphomas com-
prising 3% - 5% of all cases [1-3]. The histological deri-
vation is from the “naïve” (functionally active but
immunologically immature cells) CD5
+ B- cells residing
in the primary follicles or in the mantle zones of sec-
ondary follicles [4]. A translocation between chromo-
somes 11; 14 takes place, leading to the juxtaposition of
the cyclin D1 and the consequent over- expression of
the CCND1 gene [5]. Mantle cell lymphoma (MCL) is
composed of monomorphous small to medium sized
lymphoid cells with irregular nuclei [1,2].
At the time of diagnosis most patients have signs of
multiple lymphatic involvement, including spleen, red
bone marrow, cervical lymph nodes, liver, and gastroin-
testinal tract, usually under a condition known as “mul-
tiple small intestine polyps” [6-8]. MCL cells may also
invade the brain and spinal cord [6,8]. Most patients
present with stage III to IV of the disease including lym-
phadenopathy, hepatosplenomegaly while over 50%
include bone marrow involvement [1,2,6].
Case report
A 74- year-old Caucasian male Greek patient, presented
with mild abdominal pain and a history of recurrent
gastrointestinal bleedings over the last few years.
At the time of admission at the hospital his general
state was not indicative for an emergent situation. The
patient complained for insisting abdominal discomfort,
moderate flatulence and anorexia. Physical examination
revealed abdominal distension with flat sounds at per-
cussion, moderately decreased intestinal sounds, without
signs of localised sensitivity or peritoneal irritation.
Blood tests demonstrated normal WBC count (7.500
cells/mm
3)w i t hi n v e r t e dc e l l u l a rt y p e( N e u t r o p h i l s :
77,3%, Lymphocytes: 12,5%), moderate decrease of
Hematocrit and Hemoglobin (40% and 12,6 g/dl respec-
tively) whereas Platelet count was noticeably elevated at
662.000 cells/mm
3. Biochemistry was within normal
levels, as well as coagulation time exams, except for ele-
vated CRP count (at 45 mg/L) and decreased Albumin/
Globulin ratio. Tumour marker CA 125 was also
increased (600 U/ml - normal value < 35 in our lab).
An emergency abdominal CT scan revealed a large
solid mass invading the left lateral area of the abdominal
cavity and distended small bowel helixes (figure 1).
There was also indication of partial intestinal obstruc-
tion, at the level of sigmoid colon, with imaging of
hydroaeric levels and decreased transmission of the con-
trast agent. Gastroscopy and colonoscopy were also per-
formed, both without confirmation of large bowel and
sigmoid colon intraluminal obstruction.
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cal midline incision. A large extraluminal mass of approxi-
mate dimension 13 cm in diameter was detected at the
level of ileum. Another smaller mass of 4-5 cm was
revealed at 20 cm distance from the first finding,
presenting similar macroscopic aspect. Both masses were
solid in consistency, elastic and whitish in colour, extend-
ing transmurally through bowel walls (figures 2, 3, 4). No
signs of abdominal obstruction, or distant implantations to
other abdominal organs (liver, omentum) were confirmed.
Figure 1 Preoperative spiral abdominal Computed Tomography images revealing mass formations (white arrow pointing to the large
tumor and the red arrow pointing to the small tumor).
Figure 2 Macroscopic aspect of tumoral formations intraoperativelly, before their excision (arrows pointing to the tumors).
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Page 2 of 6A wide enterectomy of almost 37 cm was performed,
with excision of small bowel, mainly ileum, followed by
gastrointestinal anastomosis. Frozen section biopsy of
the excised specimen was positive for malignancy. A
large number of mesenteric lymph nodes were also
included in the final biopsy material.
Histology revealed diffuse, full- length, non- specific
nodular infiltration of small bowel walls reaching the
level of serosa, for both tumoral formations (figures 5, 6,
7, 8). Identification of cellular populations and immuno-
histological evaluation revealed a biphasic pattern with
lymphocytic collections formed particularly by small
lymphocytes mixed with a small population of immuno-
blasts, positive for Cyclin D1, CD5, CD20, CD35, CD79,
CIgG(), and negative for CD3, CD10, CD21, CD23,
and CD43. Limited cellular multiplication rate was
noted. Plasmocyte populations were also noticed
(positive for CD138, MUM-1, CIgG()a n dn e g a t i v ef o r
CD3 and CD20). Findings were significant for non-
Hodgkin lymphoma of B-cell origin with low malignant
potential. The tumoral origin is in the marginal cell
zone demonstrating plasmocytic differentiation and
positive CIgG(k) clonal functions. Furthermore, involve-
ment of 14 mesenteric lymph nodes was confirmed.
The patient’s postoperative course was uncomplicated,
with immediate mobilisation and normal intestinal func-
tionality. He was discharged from hospital 10 days later
in a general good status and after an interval of 22 days
he initiated adjuvant chemotherapy (CHOP regiment)
administered in a single day every 3 weeks for 6 cycles.
In addition to chemotherapy the patient received treat-
ment with monoclonal antibody Rituximab which acts
against CD20, a special molecule on the surface of
B-cell Non-Hodgkin Lymphomas.
Figure 3 Cut section of excised specimen intra operatively. The main tumor located in ileum (13-14 cm length), which infiltrates
transmurrally the intestinal wall (arrow pointing to the tumor).
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Page 3 of 6Figure 4 Cut section of the second tumor also infiltrating the intestinal wall (arrow pointing to the tumor).
Figure 5 Cytological appearance (HEX10):Intestinal Lyphoma
Infiltrating mucosa and submucosa of ileum.
Figure 6 Cytological appearance (HEX40): Neoplastic Cells
occupie small intestinal mucosa.
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Page 4 of 6A complete physical and imaging evaluation 21
months later revealed complete recovery and no signs of
remaining disease.
Discussion
Mantle cell lymphoma is an entity of B- cell malignan-
cies, belonging in the non- Hodgkin lymphomas [1,2,6].
Intestinal lymphoma is the most usual presentation of
extranodal MCL, presenting under the form of multiple
lymphomatous polyposis (MLP). Small intestine (duode-
num, jejunum and ileum) is reported to be involved in
15% - 30% of GI lymphomas [9,10].
Prognosis for intestinal malignant lymphoma is poor
due to its accelerated proliferation and the non- specific
clinical presentation of the disease. Most of the patients
have advanced stages of the disease at the time of diag-
nosis, being also delayed by the difficulty in direct visua-
lization of small intestine. Patients with obstructive
tumour masses require surgical resection.
Chemotherapy is the treatment of choice, including regi-
mens with (1) Cyclophosphamide, Hydroxydaunorubicin,
Oncovin, Prednisone or Prednisolone (CHOP), (2) Cyclo-
phosphamide, Vincristine, and Prednisone (COP), and (3)
Doxorubicin, Tteniposide, Cyclophosphamide, and Predni-
solone (AVmCP). Reports after application of AVmCP
regimen, reach response rate of 80%, with a 5- year survi-
val rate of 59%. Less aggressive regimens, such as COP,
appear to be less effective, with a response rate of 30% and
a mortality rate of 100% 3 years after treatment [4,9].
The case of extra- luminal augmentation of the
tumour is extremely seldom and double synchronous
presentation of such masses even rarer. Few cases are
reported of synchronous colonic tubular presentations
[10,11]. In non intestinal locations, MCL of the pleura
and synchronous presentation of pulmonary adenocarci-
noma may present [2] and there is also case of meta-
static MCL presenting as a prolapsed vaginal mass [12].
Conclusions
Non-polypoid lymphomas of the small bowel can be a
rare place of occurrence for mantle cell lymphomas. In
such cases of lymphomas presenting as small bowel
individual tumors, with single or multiple location, the
treatment of choice is surgical resection with appropri-
ate anastomotic procedures. Following surgery,
additional treatment with chemotherapy is also
proposed, according to the classification of malignancy.
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Figure 7 Immuno histochemical stain with APAP/CD20 × 40:
Neoplastic cells with strong positivitivy with a PanB marker.
Figure 8 Immuno histochemical stain with APAP/BCL2 × 25:
Lymphoid follicles with expansion of mantle zone.
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